NCT02617667 - CyclASol for the Treatment of Moderate to Severe Dry-eye Disease (DED) | Biotech Hunter

Enrollment

207

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

July 31, 2016

Study Completion Date

September 30, 2016

Conditions

Dry Eye Syndromes

Interventions

DRUG

Cyclosporine A

topical ocular, eye drops

DRUG

Placebo

topical ocular, eye drops

Trial Locations (4)

CYS-002 Investigational Site, Newport Beach

CYS-002 Investigational Site, Lewiston

CYS-002 Investigational Site, Andover

CYS-002 Investigational Site, Quincy